Biomerica Inc Net Assets
Biomerica Inc net assets. Based on the latest financial reports, Biomerica Inc (BMRA) has net assets worth $2.63 Million USD as of May 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($6.76 Million) and total liabilities ($4.13 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore net asset growth rate of Biomerica Inc to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $2.63 Million |
| % of Total Assets | 38.91% |
| Annual Growth Rate | -2.08% |
| 5-Year Change | -68.41% |
| 10-Year Change | -41.41% |
| Growth Volatility | 51.65 |
Net Assets of Biomerica Inc (1986–2026)
Net assets of Biomerica Inc from 1986 to 2026. This chart illustrates how Biomerica Inc's net assets have evolved over time, based on quarterly financial data. See Biomerica Inc (BMRA) net asset quality to measure how much of total assets are equity-financed.
Annual Net Assets for Biomerica Inc (1986–2026)
The table below shows the annual net assets of Biomerica Inc from 1986 to 2026. For live market cap and overall valuation, see how much is Biomerica Inc worth.
| Year | Net Assets | Change |
|---|---|---|
| 2026-05-31 | $2.63 Million | -35.93% |
| 2025-05-31 | $4.11 Million | -37.72% |
| 2024-05-31 | $6.59 Million | -43.78% |
| 2023-05-31 | $11.72 Million | +40.83% |
| 2022-05-31 | $8.32 Million | -9.78% |
| 2021-05-31 | $9.23 Million | -35.08% |
| 2020-05-31 | $14.21 Million | +257.02% |
| 2019-05-31 | $3.98 Million | -7.97% |
| 2018-05-31 | $4.33 Million | -3.64% |
| 2017-05-31 | $4.49 Million | -14.01% |
| 2016-05-31 | $5.22 Million | -6.79% |
| 2015-05-31 | $5.60 Million | -5.31% |
| 2014-05-31 | $5.91 Million | +1.36% |
| 2013-05-31 | $5.83 Million | +17.20% |
| 2012-05-31 | $4.98 Million | +14.97% |
| 2011-05-31 | $4.33 Million | +6.58% |
| 2010-05-31 | $4.06 Million | -6.56% |
| 2009-05-31 | $4.35 Million | +11.95% |
| 2008-05-31 | $3.88 Million | +121.62% |
| 2007-05-31 | $1.75 Million | +64.75% |
| 2006-05-31 | $1.06 Million | -69.89% |
| 2005-05-31 | $3.53 Million | +0.55% |
| 2004-05-31 | $3.51 Million | +8.25% |
| 2003-05-31 | $3.25 Million | -1.51% |
| 2002-05-31 | $3.30 Million | -6.37% |
| 2001-05-31 | $3.52 Million | -28.28% |
| 2000-05-31 | $4.91 Million | -20.84% |
| 1999-05-31 | $6.20 Million | 0.00% |
| 1998-05-31 | $6.20 Million | +5.08% |
| 1997-05-31 | $5.90 Million | +43.90% |
| 1996-05-31 | $4.10 Million | +28.13% |
| 1995-05-31 | $3.20 Million | -3.03% |
| 1994-05-31 | $3.30 Million | +17.86% |
| 1993-05-31 | $2.80 Million | +21.74% |
| 1992-05-31 | $2.30 Million | -8.00% |
| 1991-05-31 | $2.50 Million | -45.65% |
| 1990-05-31 | $4.60 Million | +39.39% |
| 1989-05-31 | $3.30 Million | -19.51% |
| 1988-05-31 | $4.10 Million | -10.87% |
| 1987-05-31 | $4.60 Million | -24.59% |
| 1986-05-31 | $6.10 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Biomerica Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 5224300000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Biomerica Inc Net Assets Breakdown (May 2026)
Biomerica Inc net assets breakdown by equity component as of May 2026.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $255.00K | 9.70% |
| Other Comprehensive Income | $-108.00K | -4.11% |
| Other Components | $59.43 Million | 2259.54% |
| Total Equity | $2.63 Million | 100.00% |
Biomerica Inc Competitors by Market Cap
The table below lists competitors of Biomerica Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
2020 Bulkers Ltd.
F:0FF
|
$7.80 Million |
|
Cerberus Cyber Sentinel Corp
NASDAQ:CISO
|
$7.81 Million |
|
Augros Cosmetic Packaging SA
PA:AUGR
|
$7.82 Million |
|
Manhattan Corporation Limited
F:32U
|
$7.82 Million |
|
BioLine RX Ltd
TA:BLRX
|
$7.80 Million |
|
Akbar Indomakmur Stimec Tbk
JK:AIMS
|
$7.80 Million |
|
ZHONGLIANG HLDG HD-01
F:3ZH
|
$7.80 Million |
|
Visgeneer
TWO:4197
|
$7.80 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Biomerica Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2025 to 2026, total equity changed from 4,105,000 to 2,630,000, a change of -1,475,000 (-35.9%).
- Net loss of 3,775,000 reduced equity.
- New share issuances of 2,374,000 increased equity.
- Other comprehensive income decreased equity by 3,000.
- Other factors decreased equity by 71,000.
Equity Change Factors (2025 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-3.77 Million | -143.54% |
| Share Issuances | $2.37 Million | +90.27% |
| Other Comprehensive Income | $-3.00K | -0.11% |
| Other Changes | $-71.00K | -2.7% |
| Total Change | $- | -35.93% |
Book Value vs Market Value Analysis
This analysis compares Biomerica Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.88x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.80x to 1.88x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1986-05-31 | $2.12 | $1.70 | x |
| 1987-05-31 | $1.56 | $1.70 | x |
| 1988-05-31 | $1.43 | $1.70 | x |
| 1989-05-31 | $1.10 | $1.70 | x |
| 1990-05-31 | $0.84 | $1.70 | x |
| 1991-05-31 | $0.60 | $1.70 | x |
| 1992-05-31 | $0.43 | $1.70 | x |
| 1993-05-31 | $0.42 | $1.70 | x |
| 1994-05-31 | $0.48 | $1.70 | x |
| 1995-05-31 | $0.42 | $1.70 | x |
| 1996-05-31 | $1.14 | $1.70 | x |
| 1997-05-31 | $0.93 | $1.70 | x |
| 1998-05-31 | $0.93 | $1.70 | x |
| 1999-05-31 | $0.95 | $1.70 | x |
| 2000-05-31 | $0.62 | $1.70 | x |
| 2001-05-31 | $0.31 | $1.70 | x |
| 2002-05-31 | $0.65 | $1.70 | x |
| 2003-05-31 | $0.21 | $1.70 | x |
| 2004-05-31 | $0.16 | $1.70 | x |
| 2005-05-31 | $0.16 | $1.70 | x |
| 2006-05-31 | $0.17 | $1.70 | x |
| 2007-05-31 | $0.27 | $1.70 | x |
| 2008-05-31 | $0.56 | $1.70 | x |
| 2009-05-31 | $0.62 | $1.70 | x |
| 2010-05-31 | $0.61 | $1.70 | x |
| 2011-05-31 | $0.65 | $1.70 | x |
| 2012-05-31 | $0.70 | $1.70 | x |
| 2013-05-31 | $0.78 | $1.70 | x |
| 2014-05-31 | $0.80 | $1.70 | x |
| 2015-05-31 | $0.74 | $1.70 | x |
| 2016-05-31 | $0.68 | $1.70 | x |
| 2017-05-31 | $0.54 | $1.70 | x |
| 2018-05-31 | $0.50 | $1.70 | x |
| 2019-05-31 | $0.43 | $1.70 | x |
| 2020-05-31 | $1.40 | $1.70 | x |
| 2021-05-31 | $0.77 | $1.70 | x |
| 2022-05-31 | $0.66 | $1.70 | x |
| 2023-05-31 | $0.83 | $1.70 | x |
| 2024-05-31 | $0.39 | $1.70 | x |
| 2025-05-31 | $1.79 | $1.70 | x |
| 2026-05-31 | $0.90 | $1.70 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Biomerica Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -143.54%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -84.77%
- • Asset Turnover: 0.66x
- • Equity Multiplier: 2.57x
- Recent ROE (-143.54%) is below the historical average (-30.54%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1986 | -31.15% | -111.76% | 0.23x | 1.23x | $-2.51 Million |
| 1987 | -28.26% | -68.42% | 0.30x | 1.37x | $-1.76 Million |
| 1988 | -9.76% | -28.57% | 0.29x | 1.17x | $-810.00K |
| 1989 | -27.27% | -75.00% | 0.32x | 1.15x | $-1.23 Million |
| 1990 | -21.43% | -7.32% | 0.91x | 3.21x | $-880.00K |
| 1991 | -66.67% | -11.54% | 1.42x | 4.06x | $-1.38 Million |
| 1992 | -69.23% | -11.54% | 1.22x | 4.92x | $-1.03 Million |
| 1993 | -33.33% | -5.00% | 1.27x | 5.25x | $-520.00K |
| 1995 | 7.14% | 1.09% | 1.59x | 4.14x | $-40.00K |
| 1996 | 9.76% | 4.21% | 1.56x | 1.49x | $-10.00K |
| 1997 | 11.11% | 4.35% | 1.24x | 2.06x | $40.00K |
| 1998 | 2.70% | 1.06% | 1.25x | 2.03x | $-270.00K |
| 1999 | -2.63% | -1.15% | 1.12x | 2.05x | $-480.00K |
| 2000 | -139.18% | -48.43% | 1.19x | 2.41x | $-4.17 Million |
| 2001 | -181.44% | -29.89% | 1.67x | 3.63x | $-2.82 Million |
| 2002 | -12.77% | -4.89% | 1.63x | 1.60x | $-750.29K |
| 2003 | -20.35% | -2.47% | 1.63x | 5.04x | $-333.85K |
| 2004 | -24.10% | -2.43% | 1.65x | 6.01x | $-315.83K |
| 2005 | 15.41% | 1.75% | 1.60x | 5.50x | $56.95K |
| 2006 | 21.65% | 3.20% | 2.96x | 2.28x | $123.90K |
| 2007 | 30.63% | 9.34% | 1.78x | 1.84x | $361.62K |
| 2008 | 44.03% | 34.71% | 0.96x | 1.32x | $1.32 Million |
| 2009 | 8.15% | 7.18% | 0.96x | 1.18x | $-80.62K |
| 2010 | -8.16% | -6.53% | 1.01x | 1.23x | $-737.74K |
| 2011 | 3.64% | 3.21% | 0.99x | 1.14x | $-275.59K |
| 2012 | 11.02% | 9.02% | 1.09x | 1.12x | $50.57K |
| 2013 | 9.20% | 8.30% | 1.01x | 1.10x | $-46.54K |
| 2014 | -3.65% | -4.21% | 0.79x | 1.09x | $-807.11K |
| 2015 | -5.92% | -6.68% | 0.81x | 1.09x | $-891.46K |
| 2016 | -28.73% | -29.18% | 0.90x | 1.10x | $-2.02 Million |
| 2017 | -20.24% | -15.69% | 1.15x | 1.12x | $-1.36 Million |
| 2018 | -33.89% | -26.34% | 1.07x | 1.21x | $-1.90 Million |
| 2019 | -60.11% | -46.01% | 0.99x | 1.32x | $-2.79 Million |
| 2020 | -16.46% | -34.95% | 0.39x | 1.21x | $-3.76 Million |
| 2021 | -80.70% | -103.43% | 0.61x | 1.28x | $-8.37 Million |
| 2022 | -54.43% | -24.01% | 1.66x | 1.37x | $-5.36 Million |
| 2023 | -60.90% | -133.73% | 0.37x | 1.23x | $-8.31 Million |
| 2024 | -90.70% | -110.40% | 0.59x | 1.40x | $-6.64 Million |
| 2025 | -121.14% | -93.64% | 0.89x | 1.45x | $-5.38 Million |
| 2026 | -143.54% | -84.77% | 0.66x | 2.57x | $-4.04 Million |
Industry Comparison
This section compares Biomerica Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $296,528,539
- Average return on equity (ROE) among peers: -35.30%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Biomerica Inc (BMRA) | $2.63 Million | -31.15% | 1.57x | $7.80 Million |
| Abbott Laboratories (ABT) | $2.83 Billion | 34.08% | 0.96x | $190.23 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-95.88 Million | 0.00% | 0.00x | $2.34 Million |
| Aethlon Medical Inc (AEMD) | $-3.66 Million | 0.00% | 0.00x | $1.11 Million |
| Acutus Medical Inc (AFIB) | $-11.59 Million | 0.00% | 0.00x | $903.35K |
| Adapthealth Corp (AHCO) | $15.14 Million | -140.98% | 14.05x | $850.46 Million |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $9.37 Million | 23.33% | 0.30x | $2.43 Million |
| Allurion Technologies, Inc. (ALUR) | $-77.98 Million | 0.00% | 0.00x | $21.01K |
| Autonomix Medical, Inc. Common Stock (AMIX) | $5.89 Million | -283.55% | 0.29x | $1.61 Million |
| Artivion Inc (AORT) | $276.20 Million | -4.84% | 1.86x | $1.03 Billion |
| Apyx Medical Inc (APYX) | $14.18 Million | 18.92% | 0.18x | $109.52 Million |
About Biomerica Inc
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing of diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases in North America, Asia, Europe, the Middle East, and South America. The company offers diagnostic test kits are used to analyze blood, urine, nasal, or fecal material from patients… Read more